India Pharmaceutical News

Sanofi and Regeneron announce FDA approval of Dupixent
Mumbai/Kolkata, Mar 29 : Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) Injection, the first and only biologic medicine approved for the treatment of adults with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable. Read Full Story

Dr. Morepen offers preventive therapy for Heart Diseases, Diabetes and other lifestyle related ailments
New Delhi , Mar 22 : Dr. Morepen Ltd., a wholly-owned subsidiary of Morepen Laboratories Ltd., has introduced a specialized therapy in the area of preventive cardiology and diabetology in a non-hospital environment for the first time in India. Read Full Story

NPPA issues notice to curb overcharging on medical instruments
New Delhi , Feb. 28 : National Pharmaceutical Pricing Authority issued a statement to hospitals on Tuesday that hereafter, Stent companies and hospitals must upload revised price list of cardiac stents on their respective websites in three working days. Read Full Story

Morepen Labs reports yet another growth-filled quarter
New Delhi , Feb 9 : The pharma-cum-healthcare major, Morepen Laboratories Ltd., has reported a yet another growth-filled quarter by registering a 23 percent rise in its net sales in the third quarter (Q3) of fiscal 2016-17. Read Full Story

Hilleman Laboratories awarded global patents for Oral Cholera Vaccine
New Delhi [India], Jan. 28 : Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, has announced that it has been awarded a set of global patents for its Oral Cholera Vaccine (OCV). Read Full Story

Panacea Biotec up 13 pct on US FDA nod for migraine drug
New Delhi , Jan 18 : Shares of Panacea Biotec zoomed over 13 percent intraday on Wednesday as the company received the US drug regulator's nod for a drug. Read Full Story

Cabinet approves need-based sale of surplus land of four Pharmaceutical PSUs
New Delhi , Dec. 28 : The Union Cabinet chaired by Prime Minister Narendra Modi on Wednesday approved the sale of surplus land of Hindustan Antibiotics Limited (HAL), Indian Drugs and Pharmaceuticals Limited (IDPL), Rajasthan Drugs and Pharmaceuticals Limited (RDPL) and Bengal Chemicals and Pharmaceuticals Limited (BCPL), as would be required, to meet their outstanding liabilities. Read Full Story

How Demonetization is actually benefiting the online health pharmacies
New Delhi [India], Dec 22 : With a rapidly increasing emphasis on providing affordable and accessible healthcare, the e-healthcare startups have completely disrupted the traditional business models over last few years. Considering the surge in demand for affordable and superior healthcare services, the new-age tech healthcare startups are reaching out to tap a wider network of consumer base, across the country, all this while actually reducing their overall operational costs. Bringing technology at the core of their operations, online pharmacies are offering holistic healthcare services at the click of a button and from the privacy of your homes. Read Full Story

Truuth launches its range of all dietary supplements in India
New Delhi , Sept. 28 : 2016: The first offline-online fast moving health goods (FMHG) brand, Truuth launches its dietary supplements in India. Read Full Story

Truuth, range of all dietary supplements launch in India
New Delhi , Sept. 28 : 2016: The first offline-online fast moving health goods (FMHG) brand, Truuth launches its dietary supplements in India. Read Full Story

India making a mark in pharmaceutical industry, says Nadda
Guwahati (Assam) , Sept. 28 : Union Health Minister J P Nadda on Wednesday said that India has made a mark in the pharmaceutical industry. Read Full Story

Dr Reddy's launches generic Paricalcitol injection in US
New Delhi , Sep 20 : Drug firm Dr Reddy's Laboratories announced the launch of generic Paricalcitol injection in the US for treatment associated with chronic kidney disease. Read Full Story

Fresenius Medical Care acquires dialysis service provider Sandor Nephro Services in India
New Delhi , Sep 2 : World's largest dialysis products and services provider Fresenius Medical Care announced its acquisition of 85 percent of equity interest in Indian dialysis group Sandor Nephro Services from a group of investors. Read Full Story

Medikoe appoints senior cardiothoracic surgeon Rehan Sayeed as advisor
New Delhi , Aug 27 : First online medical platform to provide access, affordable, awareness and emergency care in a single platform focussing on 360-degree healthcare and wellness services Medikoe has announced appointment of senior cardiothoracic surgeon and chairman of Motherhood Hospitals Dr. RehanSayeed as its advisor. Read Full Story

Strides Shasun gets USFDA tentative nod for Ranitidine tablets
New Delhi, Aug 24 : Strides Shasun in a BSE filing today announced receiving an approval from the US health regulator for Ranitidine tablets used for treating intestinal and stomach ulcers and gastroesophageal reflux disease. Read Full Story

Cipla rejigs top management; Umang Vohra to take over as MD
New Delhi, Aug 13 : In a major top management rejig, Cipla has announced Samina Vaziralli as the executive vice-chairman and Umang Vohra as the Managing Director and Global CEO with effect from September 1. Read Full Story

Himalaya launches HiOwna Momz, a health drink supplement for pregnant and lactating mothers
Delhi, Aug 2 : The Himalaya Drug Company recently launched HiOwna Momz, a nutritional health drink supplement for pregnant and lactating mothers. Read Full Story

Sanofi India expands diabetes portfolio, launches two diabetes drugs in India
Kolkata/Mumbai, July 19 : Sanofi-Synthelabo (India) Private Limited announced the launch of two drugs for type 2 diabetes patients in India: Lyxumia (lixisenatide) and Zemiglo (gemigliptin), an official release said. Read Full Story

Fujifilm Pharma to launch diabetes product in Japan
New Delhi, July 17 : Biocon on Saturday announced that its partner Fujifilm Pharma Co would launch bio-similar product Insulin Glargine in Japan after receiving approval from the Japanese health authority earlier this year. Read Full Story

Paras Healthcare launches Delhi centre dedicated to mothers, baby
New Delhi, July 14 : Expanding its chain of mother-and-child hospitals, Paras Healthcare Group today launched its Delhi centre, Paras Bliss Hospital. Read Full Story

Govt puts cap on prices of 42 essential drugs
New Delhi, June 27 : The government has decided to put a cap on prices of 42 essential medicines used in treatment of various critical and life-threatening diseases such as tuberculosis, cancer and cardiac diseases. Read Full Story

Cabinet withdraws Drugs and Cosmetics (Amendment) Bill, 2013
New Delhi, June 22 : The Union Cabinet, chaired by Prime Minister Narendra Modi on Wednesday decided to withdraw the Drugs and Cosmetics (Amendment) Bill, 2013, which had been introduced in the Rajya Sabha on 29.08.2013. Read Full Story

Will not just 'Make in India' but 'Innovate in India': Dilip Shanghvi
Washington D.C., June 8 : Pitching Prime Minister Narendra Modi's 'Make in India' campaign in the United States, Dilip Shanghvi, the promoter of Sun Pharmaceutical Industries, on Wednesday vowed not just to promote the campaign but will 'Innovate in India'. Read Full Story

Shruti Hassan unveils Mankind Pharma's 'ACNESTAR' range of products
New Delhi, June 6 : Mankind Pharma, one of the top pharmaceutical companies in India announced the debut of 'Acnestar', an anti-acne range of gel and soap suitable for mild to moderate skin types. Read Full Story

Bayer announces USD 62-billion for Monsanto
New Delhi, May 23 : German drugs and chemicals group Bayer announced an offer to buy U.S. seeds company Monsanto for USD 122 per share in cash, or a total value of USD 62 billion, to create the world's biggest agricultural supplier. Read Full Story

Kolkata: MedPlus celebrates a successful decade of innovation, excellence and customer satisfaction
Kolkata, May 17 : MedPlus, the leading brand in retail and online pharmacy, is celebrating its 10th anniversary this year. Read Full Story

Aurobindo Pharma receives USFDA approval for pain reliever tablets
Hyderabad, May 17 : Aurobindo Pharma Limited, manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, announced on Tuesday that it has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg, and 8 mg. Read Full Story

Sanofi withdraws painkiller Combiflam from Indian market
New Delhi, May 12 : The local unit of French drug maker Sanofi on Thursday decided to withdraw the painkiller Combiflam in batches from India after the country's drugs regulator found the lot was substandard. Read Full Story

Lupin bolsters US brands portfolio with Methergine oral tablets
Mumbai/ Baltimore, May 4 : Pharma Major Lupin Limited and its US subsidiary, Lupin Pharmaceuticals, Inc. (collectively Lupin) have announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH). Read Full Story

Lupin launches five brands in US with introduction of Methergine
New Delhi, Apr. 29 : Pharmaceutical company Lupin Ltd. is bolstering its US branded drugs portfolio with the introduction of Methergine, an oral tablet used to treat postpartum haemorrhage, in the US market. Read Full Story

50 Indian pharma manufacturers to participate in 'INTERPHEX 2016'
New Delhi, Apr 22 : Over 50 companies from India, ranging from equipment manufacturing to packaging in the pharmaceutical sector will participate in the 'India Pavilion' at the International Pharmaceutical Expo (INTERPHEX) in New York (USA) from April 26th to 28th. Read Full Story

Dr Reddy's Labs migraine injection enters US market
New Delhi, Apr 19 : Dr Reddy's Laboratories (DRL) in an announcement stated that their acute migraine treatment injection ZembraceSymTouch is now commercially available in the US market. Read Full Story

Migraine treatment injection from Dr Reddy's Lab now available in the US
Hyderabad/Princeton-NJ, Apr 19 : Promius Pharma LLC, a subsidiary of Dr. Reddy's Laboratories Ltd, has informed on Tuesday that its ZEMBRACE SymTouch (sumatriptan injection) 3 mg, which was approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S. Read Full Story

USFDA approves Sun Pharma for eye inflammation drug
New Delhi, Apr 11 : Sun Pharmaceutical Industries, the world's fifth largest specialty generic pharmaceutical company and India's largest drug maker, received an approval from the US health regulator USFDA for its non-steroid drug BromSite, which is used to treat inflammation and prevent pain in patients undergoing cataract surgery. Read Full Story

Zydus Cadila receives USFDA approval to market anti-viral drug
Ahmedabad/Mumbai, Mar 29 : Zydus Cadilla, a fully integrated, global healthcare provider, announced on Tuesday that it has received the final approval from the US FDA to market Acyclovir capsules USP, 200 mg. Read Full Story

Cadila Pharmaceuticals initiates awareness campaigns to observe 'World TB Day'
New Delhi, Mar 23 : Cadila Pharmaceuticals Limited, one of India's largest privately held pharmaceuticals companies, is planning various activities across India to raise awareness about Tuberculosis on World TB Day, that will be observed on Thursday. Read Full Story

Cadila Pharmaceuticals initiates awareness campaigns to observe 'World TB Day'
New Delhi, Mar 23 : Cadila Pharmaceuticals Limited, one of India's largest privately held pharmaceuticals companies, is planning various activities across India to raise awareness about Tuberculosis on World TB Day, that will be observed on Thursday. Read Full Story

Janssen India donates 600 courses of SIRTURO to RNTCP
Kolkata, Mar 22 : Janssen India, the pharmaceutical division of Johnson and Johnson Pvt Ltd. confirmed on Tuesday that it has donated 600 courses of SIRTURO (bedaquiline) to the Revised National Tuberculosis Control Program (RNTCP) of India for use as part of a conditional access program. Read Full Story

Pfizer stops sale of Corex cough syrup in India after ban
Mumbai, Mar 14 : Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government. Read Full Story

Indian Pharma sector poised to become future world hub
New Delhi, Feb 17 : "The Centre is coordinating closely with the states to improve productivity," said Hansraj Gangaram Ahir, Minister of Pharmaceuticals, Chemicals and Fertilizers. Read Full Story

Morepen Laboratories reports 203 percent rise in net profit and 15 percent rise in total income
New Delhi, Feb 9 : Morepen Laboratories Ltd, one of the largest producers of Montelukast Sodium (an anti-asthmatic drug), in global generic markets with an annual capacity of about 36 tons, is all set to en-cash billion dollar international market for the complex molecule. The company is tying up in European and North American markets for supplies to Abbreviated New Drug Application (ANDA) holders for the sale of Montelukast Sodium. Read Full Story

GlaxoSmithKline Consumer Healthcare Ltd records 7pc growth for Q3
New Delhi, Feb 8 : GlaxoSmithKline Consumer Healthcare Limited on Monday declared its financial results for the third quarter ended Dec 31. Read Full Story

Mankind Pharma announces entry into USmarket with an investment of approx. 300 crores
New Delhi, Jan 21 : Mankind Pharma, India's 4thlargest and fastest growing pharmaceutical company has announced its entry into US market with an investment of approx. 300 crores. Read Full Story

Fortis Healthcare organizes Free OP screening for Chennai flood victims
Chennai, Dec 9 : Fortis Healthcare has extended itsaid to the victims of the recent torrential rains and flooding that has altered the landscape of Chennai in the past few weeks. Read Full Story

MedPlus launches 'Click. Pick. Save.' service in Kolkata
Kolkata, June 30 : MedPlus, a pharmacy retailers with over 1300 stores spread across 12 states, on Tuesday announced the launch of their innovative e-commerce service 'Click, Pick. Save.' in Kolkata.
Read Full Story

Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets
New Delhi, June 23 : Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Levofloxacin Tablets, 250mg and 500mg, the generic version of Levaquin Tablets (of Ortho-McNeil), which is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax. Read Full Story

USP workshop examines ways to improve medicines quality in Asia-Pacific region
Hyderabad, May 20 : The U.S. Pharmacopeial Convention (USP), a global leader in medicines quality, is bringing together national medicines control laboratory officials for a workshop on May 26-28 in Hyderabad at USP-India on improving aspects of medicines quality in the Asia-Pacific region.
Read Full Story

Leading pharma companies adopt Cirrius PharmaCRM platform on Microsoft Azure to streamline medical engagements
New Delhi /Kolkata, Apr 21 : Cirrius PharmaCRM Digital Platform on Microsoft Azure has been adopted by leading pharmaceutical companies such as Cipla, Ranbaxy and Biocon for enabling multi-channel digitization of medical engagements. Read Full Story

NATCONPH 2015 takes off today
Kolkata, Feb 20 : NATCONPH 2015-National Conference on 'Empowering Pharmaceutical and Healthcare Professionals-Vision 2020' was inaugurated on Friday by Subhashish Maity, Director, NSHM Knowledge Campus (Kolkata) Group of Institutions at the Ahindra Mancha in Kolkata. Read Full Story

GlaxoSmithKline Consumer Healthcare Ltd records 16pc growth for Q3, FY 2014-15
New Delhi, Feb 3 : GlaxoSmithKline Consumer Healthcare Limited today declared its financial results for the third quarter ended December 31, 2014 where it recorded a net sales at Rs. 975 crores, a growth of 16pc over 2013. Read Full Story

Mylan expands Hepatitis C licensing agreement with Gilead
Pittsburgh/Hyderabad, Jan 27 : Mylan Inc. on Tuesday announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences, Inc. to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir/GS-5816, once approved, in 91developing countries. Read Full Story

HCG announces new diagnostics for cancer treatment in India
Kolkata, May 8 : HealthCare Global (HCG) Enterprises Ltd, the Specialists in Cancer Care on Thursday announced genomics-based diagnostics, a 'standard-of-care' for cancer treatment in India. Read Full Story

Caradigm joins Symphony Analytics to deliver healthcare solutions
Bangalore, May 7 : Healthcare analytics and population health company Caradigm recently signed a business cooperation agreement with analytic process integrator Symphony Analytics, to help healthcare providers rapidly improve clinical and financial outcomes through comprehensive healthcare analytics solutions. Under the agreement, Symphony Analytics will provide strategic consulting and implementation services to healthcare providers adopting the Caradigm Intelligence Platform and Caradigm analytics applications, including Caradigm Readmissions Management. Read Full Story

Shantha's Pentavalent Pediatric Vaccine prequalified by WHO
Hyderabad, May 5 : Sanofi Pasteur, the vaccines division of Sanofi on Monday announced that its pediatric pentavalent vaccine Shan5, developed and manufactured by its affiliate Shantha Biotechnics in Hyderabad, has received prequalification status from the World Health Organization (WHO). Read Full Story

Nutraceuticals slams FSSAI 'Product Approval' scheme
Mumbai, Apr 14 : The importers and manufacturers of dietary supplements, health supplements, functional foods and nutraceutical industry have deplored the alleged ambiguous scheme of 'Product Approval' by the Food Safety and Standards Authority of India (FSSAI), despite having a stay order from the Bombay High Court for 6 months. Read Full Story

Venus gets marketing nod from Venezuela for meropenem
Mumbai, Apr 3 : Venus Remedies Ltd, a research-based global pharmaceutical company, has extended its footprint in Latin America with marketing authorisation for meropenem from Venezuela, a USD 6-billion pharmaceutical market. Read Full Story

Strand receives US patent for virtual liver
Bangalore, Mar 13 : Strand Life Sciences (Strand), a Bangalore and San Francisco-based bioinformatics and systems biology company has received patent protection for its "method for predicting organ toxicity and a system thereof" in the United States (USPTO patent no. 8,645,075) effective from Feb 4. Read Full Story

Jadavpur University hosts IAPST International Conference
Kolkata, Jan 17 : The Department of Pharmaceutical Technology, Jadavpur University along with the NSHM Knowledge Campus Group of Institutions and Indian Association of Pharmaceutical Scientists and Technologists (IAPST) on Friday hosted the 2nd Pharma Tech IAPST International Conference, here. Read Full Story

Fortis paramedics specializes in emergency care
Kolkata, Nov 27 : The first batch of paramedics at Fortis Healthcare Limited completed a rigorous 1,200-hour 'Emergency Medical Paramedic' training programme conducted in collaboration with the University of Utah, USA; officials informed on Wednesday. Read Full Story

Venus Remedies to launch meropenem in Saudi Arabia
Chandigarh, Nov 20 : Venus Remedies Limited, a research-based global pharmaceutical firm, has emerged as the first Indian company to get approval for meropenem in the Gulf with marketing authorisation from the Saudi Food and Drug Authority (SFDA). Read Full Story

Next >>>